# Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

> **NCT00172094** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 189 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** NPS 1776 (800 mg)
- **DRUG:** PLACEBO
- **DRUG:** NPS 1776 (400 mg)

## Key facts

- **NCT ID:** NCT00172094
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12-31
- **Primary completion:** 2004-06-30
- **Final completion:** 2004-07-31
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2021-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00172094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00172094, "Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00172094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*